Kunhua Technology
Series B in 2023
Kunhua Technology specializes in the development of fuel cell technology and product application. It collaborates with domestic photovoltaic and energy storage companies to build an integrated wind, light, storage, and hydrogen solution, as well as to jointly expand the hydrogen energy storage market.
UWLaser is a provider of manufacturing solutions and precision laser welding equipment, specializing in complete sets of laser welding equipment and precision laser welding machines. It is a business that combines R&D, manufacturing, and sales.
Zezheng Pharmaceutical
Series B in 2021
Zezheng Bio is a pharmaceutical R&D firm that provides a drug delivery system for improved children's and generic drugs.
Zhengzheng Medicine
Series B in 2021
Zhengzheng Medicine is a pharmaceutical R&D enterprise focusing on high-end improved preparations. Founded in 2016, Zezheng Pharmaceutical is committed to taking the "ALZA" in the United States as an example, becoming a global drug delivery system (DrugDeliverySystem) research and development leader, determined to empower human health through medical technology innovation. Zezheng Medicine has established laboratories of 1,800 square meters and 8,200 square meters in Zibo, Shandong and Jiading, Shanghai respectively (including pilot workshops, high-end preparation laboratories, and high-active drug laboratories), and has deployed clinical operations and registration teams in many places around the world.
Huaxian Pharmaceutical
Series B in 2021
Huaxian Pharmaceutical is a biotechnology company. They produce highly sophisticated pharmaceutical goods for domestic and international pharmaceutical firms. They create raw materials and intermediates with a high degree of difficulty in the areas of anti-tumor, anti-virus, and anti-respiratory disorders.
Anrei Medical
Private Equity Round in 2021
Anrei Medical (HZ) Co., Ltd. is a US wholly owned and FDA registered enterprise founded in 2006, specializing in the development and manufacturing of disposable medical devices for minimally invasive procedures. Based in Hangzhou, China, the company focuses on devices utilized primarily in digestive surgeries, including gastroscopy and endoscopic retrograde cholangiopancreatography (ERCP). Anrei Medical is vertically integrated, encompassing research and development, manufacturing, distribution, and customer service, which supports its mature sales network and extensive market reach.
Cospowers
Series A in 2020
Cospowers is a technology-driven company specializing in smart lithium battery solutions for a global clientele. Founded in 2003, the company focuses on the development and manufacturing of rechargeable batteries, chargers, and power battery packs. Cospowers employs advanced technology, scientific management methods, and enhanced detection techniques to ensure the safety and reliability of its products, which have received widespread acceptance among customers. In addition to its core battery offerings, the company provides comprehensive energy storage solutions, including systems for network energy, electric energy storage, and consumer applications, all aimed at promoting clean, efficient, and economical energy use.
Thoth Medical
Series B in 2020
Thoth Medical is a developer of innovative medical wearables that integrate advanced biomedical sensor technology. The company focuses on combining wireless transmission technology, artificial intelligence algorithms, and cloud monitoring systems to enhance patient care. Thoth Medical is dedicated to delivering precise, efficient, comfortable, and safe clinical medical services, aiming to improve health outcomes through its cutting-edge wearable devices.
Kangso Medical Laboratory
Series A in 2018
Kangso Medical Laboratory, established in Beijing, specializes in molecular genetic testing services for clinical applications. With over 2,300 square meters of state-of-the-art laboratories equipped with world-class equipment, the company offers accurate disease genetic testing solutions. Kangso's dedicated team of professionals adheres to a culture of high efficiency, rigor, communication, and innovation, aiming to be the leading molecular genetic testing institution in China.
Hainan Wensheng New Material Technology
Venture Round in 2018
Hainan Wensheng New Material Technology is a prominent manufacturer and supplier of metal ores based in Haikou, China. The company specializes in the importing, manufacturing, and distribution of zircon, ilmenite, and rutile, making it one of the leading suppliers of zircon sand, titanium concentrate, and natural rutile in the country. Its strategic location in Haikou, the capital of Hainan International Tourism Island, positions the company advantageously within the industry. Hainan Wensheng New Material Technology is recognized for its commitment to quality and efficiency in the sourcing and provision of essential mineral resources.
Orbbec is a company that specializes in the design, research and development, production, and sales of 3D visual perception products. Founded by a team of experts in 3D vision and artificial intelligence, Orbbec focuses on creating advanced 3D motion sensors that enable computers to understand their environment in three dimensions. The company aims to make high-quality 3D cameras affordable and widely accessible, as it believes that these technologies will become essential for the future of intelligent computing. Orbbec's vision anticipates a time when the integration of 3D cameras in computing will be ubiquitous, transforming how machines interact with the world.
Beijing ACCB Biotech
Series C in 2017
Beijing ACCB Biotech Ltd., established in 2004, specializes in developing and commercializing molecular cancer detection and diagnostic technologies. The company offers a range of products and services, including kits and tests for cancer screening, early detection, prognosis evaluation, personalized cancer therapies, and recurrence monitoring. Its key products are EnzymAct, a non-invasive cancer screening kit, and BiomarkXP, a service platform for prognosis evaluation and therapeutic monitoring. ACCB Biotech's technologies cater to various cancer types, such as esophageal, gastric, colon, and breast cancer, among others. The company operates state-of-the-art facilities, spanning over 3,000 square meters, and adheres to stringent cleanliness standards. ACCB Biotech has a strategic partnership with Beijing Jianxun Fangcheng Software Technology Co. Ltd. and has successfully gained approval for its EnzymAct product from the State Food and Drug Administration.
Yitongwen
Private Equity Round in 2017
Yitongwen provides an overall preschool education solutions that focusing on content innovation. It is a cultural and creative enterprise integrating educational technology innovation, product design innovation, network training innovation, and educational service innovation. , educational books, educational equipment, teacher training, network services and other high-quality products. Among them are educational equipment products that include five series of learning materials, game materials, sports materials, living materials, and home education.
Inno Laser
Venture Round in 2016
Inno Laser Technology Co., Ltd., established in 2011 and based in Shenzhen, China, specializes in the research, development, production, and sale of lasers for micro-machining applications. The company offers a range of lasers, including compact medium and low power nanosecond lasers, integrated hybrid design picosecond lasers, and MOPA nanosecond/sub-nanosecond lasers, catering to diverse industries such as 3D printing, PCB/FPC cutting, glass processing, and photovoltaic chip processing. Inno Laser also provides customized laser modules tailored to specific customer needs.
Beijing ACCB Biotech
Venture Round in 2016
Beijing ACCB Biotech Ltd., established in 2004, specializes in developing and commercializing molecular cancer detection and diagnostic technologies. The company offers a range of products and services, including kits and tests for cancer screening, early detection, prognosis evaluation, personalized cancer therapies, and recurrence monitoring. Its key products are EnzymAct, a non-invasive cancer screening kit, and BiomarkXP, a service platform for prognosis evaluation and therapeutic monitoring. ACCB Biotech's technologies cater to various cancer types, such as esophageal, gastric, colon, and breast cancer, among others. The company operates state-of-the-art facilities, spanning over 3,000 square meters, and adheres to stringent cleanliness standards. ACCB Biotech has a strategic partnership with Beijing Jianxun Fangcheng Software Technology Co. Ltd. and has successfully gained approval for its EnzymAct product from the State Food and Drug Administration.
Kuai CTO
Angel Round in 2016
Kuai CTO provides big data, cloud computing, smart hardware and artificial intelligence services.
Renren Inc. operates primarily as a used automobile retailer in the People's Republic of China, offering a range of vehicles from brands such as Audi, BMW, Mercedes-Benz, Land Rover, and Porsche. The company facilitates financing options for customers through partnerships with financial services and provides credit financing to used car dealers. Additionally, Renren offers value-added services, including warranties, insurance, and after-sale support. The company leverages its online platforms, including the Kaixin Auto app and other vertical channels, to reach customers. Beyond the automotive sector, Renren also develops the Chime platform, which provides lead generation and customer relationship management solutions tailored for real estate professionals in the United States. Furthermore, it offers online and mobile services for the trucking industry. Originally founded in 2002 as Oak Pacific Interactive, the company rebranded to Renren Inc. in 2010, and is headquartered in Beijing.
Renren Games
Series A in 2016
Renren Games offers gaming and entertainment services.
Bay Environmental Technology (Bayeco)
Venture Round in 2016
Bay Environmental Technology (Beijing) Corp, commonly known as Bayeco, specializes in environmental protection solutions tailored for the petrochemical and industrial sectors. The company focuses on air pollution control, offering services such as volatile organic compound (VOCs) treatment, vapor recovery systems, and PM2.5 treatment. Its applications are designed to address the needs of refinery plants, gas stations, oil depots, and process boilers. Bayeco has distinguished itself in the industry by being recognized as the first state environmental protection engineering center for VOC control in petrochemical industries. Through its comprehensive services, Bayeco aims to assist clients in effectively managing and reducing environmental pollutants, thereby promoting cleaner industrial operations.
Mingde Bio
Private Equity Round in 2016
Mingde Bio is a high-tech biotechnology company that specializes in the R&D, production, and sales of rapid diagnostic reagents. The company has more than 30 POCT rapid diagnostic reagent products and has become one of the most comprehensive domestic companies with product lines. In July 2018, it was officially listed on the Small and Medium-sized Board of the Shenzhen Stock Exchange with the stock code 002932.
Waluer
Private Equity Round in 2016
Waluer is an integrated service provider in the field of mobile culture and entertainment industry. Its main business is to provide content integrated distribution, channel marketing promotion and product payment calculation for mobile entertainment products.
Junmeng Game Online Game Industry
Private Equity Round in 2016
Junmeng Game Online Game Industry is engaged in the development and operation of web games and social games. Established in 2009, Junmeng is composed by a large number of elite talents and venture capital of domestic first-tier online game companies.
Tiansheng Pharmaceutical Group
Private Equity Round in 2016
Tiansheng Pharmaceutical Group is a Chinese pharmaceutical company engaged in the research, development, production, and sales of a wide range of pharmaceutical products. The company specializes in manufacturing various medicines, including baikejing granules and pediatric lung cough granules, addressing diverse therapeutic areas such as respiratory, digestive, cardiovascular, oncology, and gynecological health. Tiansheng also involves itself in the circulation of pharmaceuticals and the planting and processing of Chinese herbal medicine. Their products are accessible for online shopping, and customer inquiries are managed through multiple channels, including phone, email, and online applications.
Kawin Technology
Venture Round in 2016
Beijing Kawin Technology Share-Holding Co., Ltd. is a biotechnology company based in the Beijing Economy-Technology Development Area, known as the "Pharmaceutical Valley." The company specializes in developing healthcare solutions for liver diseases, offering products such as Pirfenidone Tablets, Peginterferon Alfacon-2 Injection, and Compound Glycyrrhizin Capsules. Since its establishment, Kawin Technology has formed strategic partnerships with notable firms, including Legend Capital, Haitong Capital, and Cybernaut. Recognized as a High & New Technology Enterprise by the Beijing Municipal Science & Technology Commission, the company has also been listed among the Hundred Pilot Enterprises and the Top 100 Most-Promising Enterprises by Zhongguancun Technology Park, often referred to as China’s Silicon Valley.
Biomarker Technologies
Private Equity Round in 2016
Biomarker Technologies, founded in 2009 and headquartered in Beijing, China, specializes in genomic services that integrate science, technology, and medical applications. The company offers a range of services including gene sequencing, scientific research, medical testing, and biological research, aimed at enhancing research capabilities for its clients. With a dedicated R&D team of over 500 highly skilled professionals, including technical staff, senior engineers, bioinformaticians, and experts in biotechnology, agriculture, and medicine, Biomarker Technologies is positioned as a key player in the genetic industry.
H&R Century (欢瑞世纪) is a company focused on the investment, production, and publication of TV series and the development of relevant industries. It is focused on the market of young audience, and takes youth, vigor, and fashion as standards to create works that represent the tastes and aesthetic interests of young people. H&R Century has produced works such as "Heart Lock Jade Palace", "Palace Ⅱ", "The Cost of The Bachelorettes”, “Midsummer Clear Day", "Times of The Bachelorettes, Painted Skin Ⅱ", and more. It has also invested in filming several films such as "Painted Skin Ⅱ", "Tiny Times", “Tiny Times Ⅱ”, and “Aoki Era". Founded in 2006, H&R Century has 14 male artists and 12 female artists, and has signed with 7 Star Studios including Yang Mi, Liu Kaiwei, Tang Yan, Jia Nailiang, and more.
Shenzhen New Industries Biomedical Engineering
Private Equity Round in 2016
Shenzhen New Industries Biomedical Engineering Co., Ltd. is a biomedical company based in Shenzhen, China, founded in 1995. The company specializes in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents. It provides a range of products, including immunology and clinical chemistry systems, as well as immunoassay and clinical chemistry reagent kits. Shenzhen New Industries serves hospitals and laboratories both domestically and internationally, and its operations include dedicated centers for research and development, production of reagents and instruments, and sales and marketing activities.
HUNAN TEA GROUP CO.,LTD
Private Equity Round in 2016
Hunan Tea Industry is a supplier of tea products. They provide products that include tea planting, processing, scientific research, sales, and tea. An online inquiry form is available on the company's website.
Tiansheng Pharmaceutical
Private Equity Round in 2016
Tiansheng Pharmaceutical is a manufacturer of gelatin products and Chinese patent medicines.
Biomarker Technologies
Series B in 2015
Biomarker Technologies, founded in 2009 and headquartered in Beijing, China, specializes in genomic services that integrate science, technology, and medical applications. The company offers a range of services including gene sequencing, scientific research, medical testing, and biological research, aimed at enhancing research capabilities for its clients. With a dedicated R&D team of over 500 highly skilled professionals, including technical staff, senior engineers, bioinformaticians, and experts in biotechnology, agriculture, and medicine, Biomarker Technologies is positioned as a key player in the genetic industry.
Shanghai Medicilon
Series B in 2015
Shanghai Medicilon Inc. is a leading contract research organization (CRO) based in Shanghai, China, specializing in drug discovery and development services for pharmaceutical and biotechnology companies globally. Established in 2004, the company offers a broad array of services, including medicinal chemistry, process development, drug formulation, and preclinical research. Its biology services encompass various fields such as recombinant protein production, discovery biology, and molecular modeling. Additionally, Medicilon provides pharmacology services across numerous disease models, including cancer and neurological disorders, along with bioanalytical support for both large and small molecules. The firm aims to meet the innovative needs of the global pharmaceutical industry by leveraging its extensive technical expertise and comprehensive service offerings, which are compliant with both domestic and international regulatory standards.
HUNAN TEA GROUP CO.,LTD
Series A in 2013
Hunan Tea Industry is a supplier of tea products. They provide products that include tea planting, processing, scientific research, sales, and tea. An online inquiry form is available on the company's website.
Shanghai Medicilon
Series B in 2013
Shanghai Medicilon Inc. is a leading contract research organization (CRO) based in Shanghai, China, specializing in drug discovery and development services for pharmaceutical and biotechnology companies globally. Established in 2004, the company offers a broad array of services, including medicinal chemistry, process development, drug formulation, and preclinical research. Its biology services encompass various fields such as recombinant protein production, discovery biology, and molecular modeling. Additionally, Medicilon provides pharmacology services across numerous disease models, including cancer and neurological disorders, along with bioanalytical support for both large and small molecules. The firm aims to meet the innovative needs of the global pharmaceutical industry by leveraging its extensive technical expertise and comprehensive service offerings, which are compliant with both domestic and international regulatory standards.
Dream is a company that offers game creation services with the goal of creating a variety of web games, social games, and mobile Internet games. Clients can access a variety of online games cause of the company's gaming development services, which include numerous cross-platform gaming facilities that are also exported to other markets.